Načítá se...
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer
SIMPLE SUMMARY: In randomized trials, both chemotherapy and androgen-receptor signaling inhibitors provided significant survival benefits in patients with metastatic prostate cancer (mPCa). However, it is largely unknown to what extent these therapeutic advances have impacted the general, real-world...
Uloženo v:
| Vydáno v: | Cancers (Basel) |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7650780/ https://ncbi.nlm.nih.gov/pubmed/33022939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102855 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|